Form 4 for MGX Metagenomi Therapeutics, Inc.
Accepted 2025-06-09 00:00:00 ET · period of report 2025-06-06 · accession 0000950170-25-083949 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-09 | 2025-06-06 | MGX | Wapnick Pamela | CFO | S - Sale | $1.75 | -1,576 | 72.1K | -2% | -$2,758 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-06 | S | D | 1,576 | $1.75 | 72,108 | D | — | — |